Skip to main content
. 2017 Oct 25;8(55):94893–94899. doi: 10.18632/oncotarget.22046

Table 2. The association between bodyweight change and UA level over 2 years.

ΔBMI from ≥25 kg/m2
to <25 kg/m2 (n=1219)
ΔBMI from BMI <25 kg/m2
to ≥25 kg/m2 (n=178)
ΔBMI from BMI <25 kg/m2 to <25 kg/m2 (n=1118) ΔBMI from ≥25 kg/m2 to ≥25 kg/m2 (n=2163)
Age (years), Number (%)
>60 51(5.06) 16(9.0) 677(60.6) 264(12.2)
35-60 963(79.9) 44(24.7) 262(23.4) 1538(71.1)
18-35 205(16.8) 118(66.3) 179(16.0) 361(16.7)
Waist circumference (cm)
Baseline 93.57±13.37 78.56±8.35 77.56±8.35 92.16±12.58
Post-intervention 82.45±9.23* 86.19±9.69* 76.32±7.79 91.44±10.85
SUA
Base line 9.37±1.18 8.26±1.23 8.53±1.47 9.14±1.41
Post-intervention 6.82 ± 1.25* 8.14±1.58 7.05±1.63* 8.91±1.59
Patients with normal SUA post intervention,n% 1102(90.4) 35(19.7) 843(75.4) 775(35.8)
Patients not on urate-lowering agents, n% 311(25.5) 87(48.9) 346(30.9) 46(2.1)

*P<0.05, post-intervention versus baseline.

ΔBMI: the change of BMI.